German & European Managed Hotel Financing:
Performance Tests — When an Operational Metric Becomes a Credit Event 🏨📉

In my last post, I looked at the Direct Agreement and why it is often the most important — and most delayed — document in a managed hotel financing. This post addresses a related risk that sits on the other side of the table: performance tests under the HMA.

A performance test is not just an operational metric. In a managed hotel financing, it can trigger a chain of events that ends with the operator walking, the brand disappearing, and the lender holding an asset that has lost a significant part of its value overnight.

1) What performance tests are and why they exist 📊

Most HMAs with international operators contain a performance test — a mechanism that allows the owner to terminate the management agreement if the hotel underperforms against agreed benchmarks over a sustained period.

The logic is straightforward: the owner is paying management fees for professional hotel management. If the hotel consistently underperforms, the owner needs the ability to replace the operator. Without this right, the owner is locked into a long-term contract with no exit — regardless of results.

Typical performance test mechanics include:

A benchmark: usually GOP (Gross Operating Profit) or RevPAR measured against a competitive set or a budget target.
A test period: typically two consecutive fiscal years of underperformance (sometimes with a minimum threshold, e.g., below 80–90% of the agreed benchmark).
An operator cure right: the operator may have the right to “cure” a failed test by paying the shortfall (sometimes called an operator performance guarantee or top-up).
A termination right: if the test is failed and not cured, the owner may terminate the HMA on notice.

So far, this looks like a borrower/owner protection. The question for lenders is: what happens to the financing when the owner exercises — or fails to exercise — that right?

2) Why lenders need to care about the owner’s termination right ⚠️

In a managed hotel financing, the HMA is the cash flow engine. The operator runs the hotel, manages the brand relationship, maintains the distribution channels, and employs (or oversees) the staff. If the HMA terminates, all of that goes with it.

A performance test failure creates two risks for the lender — and they pull in opposite directions:

Risk 1: The owner terminates the HMA. The hotel loses its operator and potentially its brand. RevPAR drops. The asset needs a replacement operator, which — as I covered in the Direct Agreement post — takes months. During the transition, the lender’s collateral is worth materially less.
Risk 2: The owner does not terminate. The hotel continues to underperform under the same operator. The borrower’s debt service capacity deteriorates. Financial covenants in the loan may be breached. The lender is watching the asset decline but has no mechanism to force a change.

This is the core tension: a performance test failure is simultaneously an HMA event and a financing event. The loan documents and the HMA need to be drafted in a way that gives the lender visibility and influence over how the borrower responds — without overriding the commercial judgment that only the owner can make.

3) The compounding problem: when HMA risk meets loan covenant risk 🔥

In many managed hotel financings, the same underperformance that triggers a performance test under the HMA will also trigger — or come close to triggering — a financial covenant breach under the Facilities Agreement.

A scenario: a managed city hotel underperforms for two consecutive years. GOP falls below 85% of the competitive set benchmark. The performance test under the HMA is failed. At the same time, TTM DSCR drops below the cash trap trigger in the loan documents.

The borrower now faces three things at once:

A cash trap under the loan (distributions locked, surplus swept).
A decision on whether to terminate the operator (which costs money, takes time, and creates uncertainty).
Reduced cash flow to fund FF&E reserves, debt service, and a potential operator transition — all simultaneously.

If the loan documents do not anticipate this scenario, the lender may find that the borrower is contractually trapped: unable to fund a transition because cash is locked, unable to keep the underperforming operator because the lender wants change, and unable to bring in a replacement without lender consent that the loan documents make difficult to obtain under stress.

4) What the loan documents need to address ✅

A well-drafted Facilities Agreement in a managed hotel financing addresses the interaction between HMA performance tests and loan mechanics in several ways:

Notification. The borrower is required to notify the lender of any performance test failure under the HMA within a defined period. This sounds basic, but without it the lender may not know a test has been failed until the borrower has already decided whether to terminate or waive.
Consultation before waiver. The borrower may not waive a performance test failure or decline to exercise a termination right without prior consultation with (or consent of) the lender. The lender needs a say in whether the operator stays or goes — because the answer directly affects asset value and debt service capacity.
Replacement operator approval. If the borrower terminates the HMA, the replacement operator must meet defined criteria (brand standard, geographic experience, financial standing) and be approved by the lender. A pre-agreed shortlist or qualification framework speeds this up under time pressure.
Transition carve-out in the cash trap. If the hotel is in a cash trap at the time of an operator transition, the waterfall needs to allow for transition costs — re-branding, system migration, staff retraining, interim management fees. Without a carve-out, the cash trap blocks the very spending needed to stabilise the asset.
Stabilisation period. A defined period (typically 6–12 months) following an operator replacement during which covenant testing is adjusted or suspended, recognising that a hotel in transition will underperform its normal run-rate.

5) The operator’s cure right: a comfort or a complication? 🤔

Many HMAs give the operator the right to cure a failed performance test by paying the shortfall to the owner. On paper, this is a good outcome: the hotel stays managed, the brand stays, and the owner receives compensation for the underperformance.

In practice, lenders need to look carefully at how the cure right interacts with the financing:

Does the cure payment flow through the account structure and into the waterfall, or does it sit outside the secured cash flows?
Does a cured test reset the clock, or does a pattern of repeated cures signal a deeper problem that the lender needs to address?
Is the cure right unlimited, or does it expire after a certain number of consecutive failures?

An operator who cures every test year after year is keeping the HMA alive — but the hotel is still underperforming. The loan documents may need to treat repeated cure payments differently from genuine performance recovery.

Takeaway

Performance tests under the HMA are not just an operational matter between owner and operator. In a managed hotel financing, they are credit events — and the loan documentation needs to treat them as such. Lenders who do not have visibility over performance test results, influence over the borrower’s response, and a workable framework for operator transitions are exposed to a risk they may not see coming until it is too late.

The goal is not to give the lender veto power over hotel management decisions. It is to ensure that when operational underperformance reaches the point where the management relationship is at risk, the lender has enough information, contractual rights, and practical headroom to protect its position.

www.djm.legal

Disclaimer: This article is for general information purposes only and does not constitute legal advice.

#hotelfinancing #Germany #realestatefinance #LMA #hospitalityrealestate #bankinglaw #crossborderfinance #HMA #performancetest #hoteloperator